Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Parallel Group Phase III Multi-center Trial to Compare Twice Daily Topical Application of M518101, Daivonex® and Vehicle in Patients With Plaque Psoriasis III

NCT01989429 is registered in ClinicalTrials.gov with Maruho Europe Limited as lead sponsor.

NCT NCT01989429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01989429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Parallel Group Phase III Multi-center Trial to Compare Twice Daily Topical Application of M518101, Daivonex® and Vehicle in Patients With Plaque Psoriasis III
Lead sponsor
Maruho Europe Limited
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2014
Enrollment
788 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis